Heart Disease Trial, Recruiting NCT07259278 Sponsor: China National Center for Cardiovascular Diseases Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT07259278
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older who have been diagnosed with coronary heart disease
  • People whose heart condition has been assessed as low-risk for cardiovascular events during physical activity, and who also score as low-risk on a standard heart risk assessment tool called the GRACE score
  • People who, or whose close family members, are able to use a smartphone and apps
  • People who are willing to take part and sign a consent form

Who may not be able to join:

  • People who have a blockage of more than 50% in the main artery supplying the heart, or more than 70% blockage in other major heart arteries
  • People who are scheduled to have a procedure to restore blood flow to the heart within the next 3 months
  • People who have had a heart attack within the past month
  • People with severe difficulties in thinking, memory, or understanding
  • People whose ability to exercise is severely limited
  • People with cancer that has reached an advanced stage
  • People whose life expectancy is estimated to be less than 3 months
  • People with severe failure of multiple organs in the body
  • People whose doctor has determined, after assessment, that home-based exercise rehabilitation would not be appropriate for them for any other reason
  • People who are not willing to sign a written consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 010-88322413

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
China National Center for Cardiovascular Diseases
Registry
ClinicalTrials.gov
Start date
1 December 2025
Est. completion
30 November 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Peak oxygen consumption (VO2peak)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov